BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 31394639)

  • 41. Caspase-mediated Cdk2 activation is a critical step to execute transforming growth factor-beta1-induced apoptosis in human gastric cancer cells.
    Kim SG; Kim SN; Jong HS; Kim NK; Hong SH; Kim SJ; Bang YJ
    Oncogene; 2001 Mar; 20(10):1254-65. PubMed ID: 11313870
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
    Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
    Oncogene; 1999 May; 18(21):3290-302. PubMed ID: 10359535
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
    Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
    Oncogene; 1999 Jul; 18(30):4313-25. PubMed ID: 10439039
    [TBL] [Abstract][Full Text] [Related]  

  • 44. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
    Akiyama T; Yoshida T; Tsujita T; Shimizu M; Mizukami T; Okabe M; Akinaga S
    Cancer Res; 1997 Apr; 57(8):1495-501. PubMed ID: 9108451
    [TBL] [Abstract][Full Text] [Related]  

  • 45. F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after gamma-irradiation due to p21WAF1/CIP1 degradation.
    Malashicheva AB; Kislyakova TV; Aksenov ND; Osipov KA; Pospelov VA
    Oncogene; 2000 Aug; 19(34):3858-65. PubMed ID: 10951579
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Degradation of p21CDKN1A after DNA damage is independent of type of lesion, and is not required for DNA repair.
    Savio M; Coppa T; Cazzalini O; Perucca P; Necchi D; Nardo T; Stivala LA; Prosperi E
    DNA Repair (Amst); 2009 Jul; 8(7):778-85. PubMed ID: 19321391
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of CEACAM1 isoforms in an in vivo model of mammary morphogenesis: mutational analysis of the cytoplasmic domain of CEACAM1-4S reveals key residues involved in lumen formation.
    Yokoyama S; Chen CJ; Nguyen T; Shively JE
    Oncogene; 2007 Dec; 26(55):7637-46. PubMed ID: 17546042
    [TBL] [Abstract][Full Text] [Related]  

  • 48. p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells.
    Cayrol C; Knibiehler M; Ducommun B
    Oncogene; 1998 Jan; 16(3):311-20. PubMed ID: 9467956
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mutational analysis of the Cy motif from p21 reveals sequence degeneracy and specificity for different cyclin-dependent kinases.
    Wohlschlegel JA; Dwyer BT; Takeda DY; Dutta A
    Mol Cell Biol; 2001 Aug; 21(15):4868-74. PubMed ID: 11438644
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Binding of calmodulin to the carboxy-terminal region of p21 induces nuclear accumulation via inhibition of protein kinase C-mediated phosphorylation of Ser153.
    Rodríguez-Vilarrupla A; Jaumot M; Abella N; Canela N; Brun S; Díaz C; Estanyol JM; Bachs O; Agell N
    Mol Cell Biol; 2005 Aug; 25(16):7364-74. PubMed ID: 16055744
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage.
    Karimian A; Ahmadi Y; Yousefi B
    DNA Repair (Amst); 2016 Jun; 42():63-71. PubMed ID: 27156098
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reactive oxygen species-mediated activation of the Akt/ASK1/p38 signaling cascade and p21(Cip1) downregulation are required for shikonin-induced apoptosis.
    Ahn J; Won M; Choi JH; Kim YS; Jung CR; Im DS; Kyun ML; Lee K; Song KB; Chung KS
    Apoptosis; 2013 Jul; 18(7):870-81. PubMed ID: 23546866
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21.
    Li Y; Jenkins CW; Nichols MA; Xiong Y
    Oncogene; 1994 Aug; 9(8):2261-8. PubMed ID: 7913544
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of the regulatory region required for ubiquitination of the cyclin kinase inhibitor, p21.
    Fukuchi K; Hagiwara T; Nakamura K; Ichimura S; Tatsumi K; Gomi K
    Biochem Biophys Res Commun; 2002 Apr; 293(1):120-5. PubMed ID: 12054572
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phosphorylation of the cell cycle inhibitor p21Cip1/WAF1 by Pim-1 kinase.
    Wang Z; Bhattacharya N; Mixter PF; Wei W; Sedivy J; Magnuson NS
    Biochim Biophys Acta; 2002 Dec; 1593(1):45-55. PubMed ID: 12431783
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2.
    Du WW; Yang W; Liu E; Yang Z; Dhaliwal P; Yang BB
    Nucleic Acids Res; 2016 Apr; 44(6):2846-58. PubMed ID: 26861625
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Knockdown of SMAD3 inhibits the growth and enhances the radiosensitivity of lung adenocarcinoma via p21
    Niu H; Huang Y; Yan L; Zhang L; Zhao M; Lu T; Yang X; Chen Z; Zhan C; Shi Y; Wang Q
    Int J Biol Sci; 2020; 16(6):1010-1022. PubMed ID: 32140069
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cytoplasmic Localization of Cyclin Kinase Inhibitor p21 Delays the Progression of Apoptosis.
    Arai D; Nomura N; Fukuchi K; Gomi K
    Cancer Genomics Proteomics; 2006; 3(1):29-37. PubMed ID: 31394639
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The N-terminal 15-48 region of cyclin kinase inhibitor p21 is a determinant of basal expression.
    Nomura N; Yamaguchi F; Fukuchi K
    Cancer Genomics Proteomics; 2007; 4(2):71-80. PubMed ID: 17804869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.